,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1302207,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0003626,"Carbonic anhydrase 5A, mitochondrial",https://www.drugbank.ca/bio_entities/BE0003626,P35218,"Carbonic anhydrase 5A, mitochondrial",763.0,CA5A,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
1,1302208,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0003627,"Carbonic anhydrase 5B, mitochondrial",https://www.drugbank.ca/bio_entities/BE0003627,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",11238.0,CA5B,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
2,1302209,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0003628,Carbonic anhydrase 6,https://www.drugbank.ca/bio_entities/BE0003628,P23280,Carbonic anhydrase 6,765.0,CA6,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
3,1302370,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0003629,Carbonic anhydrase 7,https://www.drugbank.ca/bio_entities/BE0003629,P43166,Carbonic anhydrase 7,766.0,CA7,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
4,1302371,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0002437,Carbonic anhydrase 9,https://www.drugbank.ca/bio_entities/BE0002437,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
5,1302372,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0001653,Carbonic anhydrase 12,https://www.drugbank.ca/bio_entities/BE0001653,O43570,Carbonic anhydrase 12,771.0,CA12,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
6,1302373,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0003634,Carbonic anhydrase 14,https://www.drugbank.ca/bio_entities/BE0003634,Q9ULX7,Carbonic anhydrase 14,23632.0,CA14,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
7,1302374,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0001209,Casein kinase II subunit alpha,https://www.drugbank.ca/bio_entities/BE0001209,P68400,Casein kinase II subunit alpha,1457.0,CSNK2A1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:19414254|PMID:16610779|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/19414254|https://www.ncbi.nlm.nih.gov/pubmed/16610779|https://www.ncbi.nlm.nih.gov/pubmed/10592235,19414254|16610779|10592235,,"Sekiguchi Y, Nakaniwa T, Kinoshita T, Nakanishi I, Kitaura K, Hirasawa A, Tsujimoto G, Tada T: Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid. Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. doi: 10.1016/j.bmcl.2009.04.076.  Epub 2009 Apr 22.|Cozza G, Bonvini P, Zorzi E, Poletto G, Pagano MA, Sarno S, Donella-Deana A, Zagotto G, Rosolen A, Pinna LA, Meggio F, Moro S: Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application. J Med Chem. 2006 Apr 20;49(8):2363-6.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
8,1302375,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,https://www.drugbank.ca/bio_entities/BE0003761,P17612,cAMP-dependent protein kinase catalytic subunit alpha,5566.0,PRKACA,9606.0,Homo sapiens (human),Inhibitor,,,PMID:9581512,https://www.ncbi.nlm.nih.gov/pubmed/9581512,9581512,,"Wang BH, Lu ZX, Polya GM: Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol. Planta Med. 1998 Apr;64(3):195-9."
9,1302376,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0001132,Protein kinase C alpha type,https://www.drugbank.ca/bio_entities/BE0001132,P17252,Protein kinase C alpha type,5578.0,PRKCA,9606.0,Homo sapiens (human),Inhibitor,,,PMID:9581512,https://www.ncbi.nlm.nih.gov/pubmed/9581512,9581512,,"Wang BH, Lu ZX, Polya GM: Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol. Planta Med. 1998 Apr;64(3):195-9."
10,1302518,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0000872,Protein kinase C beta type,https://www.drugbank.ca/bio_entities/BE0000872,P05771,Protein kinase C beta type,5579.0,PRKCB,9606.0,Homo sapiens (human),Inhibitor,,,PMID:9581512,https://www.ncbi.nlm.nih.gov/pubmed/9581512,9581512,,"Wang BH, Lu ZX, Polya GM: Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol. Planta Med. 1998 Apr;64(3):195-9."
11,1302519,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0001316,Tyrosine-protein kinase SYK,https://www.drugbank.ca/bio_entities/BE0001316,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),Inhibitor,,,PMID:16610779,https://www.ncbi.nlm.nih.gov/pubmed/16610779,16610779,,"Cozza G, Bonvini P, Zorzi E, Poletto G, Pagano MA, Sarno S, Donella-Deana A, Zagotto G, Rosolen A, Pinna LA, Meggio F, Moro S: Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application. J Med Chem. 2006 Apr 20;49(8):2363-6."
12,1302520,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0000577,Squalene monooxygenase,https://www.drugbank.ca/bio_entities/BE0000577,Q14534,Squalene monooxygenase,6713.0,SQLE,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11520216,https://www.ncbi.nlm.nih.gov/pubmed/11520216,11520216,,"Abe I, Kashiwagi Y, Noguchi H, Tanaka T, Ikeshiro Y, Kashiwada Y: Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase. J Nat Prod. 2001 Aug;64(8):1010-4."
13,1302521,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0003543,Cytochrome P450 1A1,https://www.drugbank.ca/bio_entities/BE0003543,P04798,Cytochrome P450 1A1,1543.0,CYP1A1,9606.0,Homo sapiens (human),Inhibitor|Inducer,,,PMID:19469472|PMID:8024593,https://www.ncbi.nlm.nih.gov/pubmed/19469472|https://www.ncbi.nlm.nih.gov/pubmed/8024593,19469472|8024593,,"Gonzalez-Sarrias A, Azorin-Ortuno M, Yanez-Gascon MJ, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC: Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1. J Agric Food Chem. 2009 Jun 24;57(12):5623-32. doi: 10.1021/jf900725e.|Barch DH, Rundhaugen LM, Thomas PE, Kardos P, Pillay NS: Dietary ellagic acid inhibits the enzymatic activity of CYP1A1 without altering hepatic concentrations of CYP1A1 or CYP1A1 mRNA. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1477-82."
14,1302522,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0003533,Cytochrome P450 2E1,https://www.drugbank.ca/bio_entities/BE0003533,P05181,Cytochrome P450 2E1,1571.0,CYP2E1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:8625497,https://www.ncbi.nlm.nih.gov/pubmed/8625497,8625497,,"Ahn D, Putt D, Kresty L, Stoner GD, Fromm D, Hollenberg PF: The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis. 1996 Apr;17(4):821-8."
15,1302523,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0001066,Solute carrier family 22 member 6,https://www.drugbank.ca/bio_entities/BE0001066,Q4U2R8,Solute carrier family 22 member 6,9356.0,SLC22A6,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:15870380|PMID:19953504,https://www.ncbi.nlm.nih.gov/pubmed/15870380|https://www.ncbi.nlm.nih.gov/pubmed/19953504,15870380|19953504,,"Whitley AC, Sweet DH, Walle T: The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metab Dispos. 2005 Aug;33(8):1097-100. Epub 2005 May 3.|VanWert AL, Gionfriddo MR, Sweet DH: Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm Drug Dispos. 2010 Jan;31(1):1-71. doi: 10.1002/bdd.693."
16,1302524,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0000879,Solute carrier family 22 member 11,https://www.drugbank.ca/bio_entities/BE0000879,Q9NSA0,Solute carrier family 22 member 11,55867.0,SLC22A11,9606.0,Homo sapiens (human),,,,PMID:15870380,https://www.ncbi.nlm.nih.gov/pubmed/15870380,15870380,,"Whitley AC, Sweet DH, Walle T: The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metab Dispos. 2005 Aug;33(8):1097-100. Epub 2005 May 3."
17,1302525,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0000267,Carbonic anhydrase 1,https://www.drugbank.ca/bio_entities/BE0000267,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
18,1302690,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0000322,Carbonic anhydrase 2,https://www.drugbank.ca/bio_entities/BE0000322,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
19,1302691,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0003625,Carbonic anhydrase 3,https://www.drugbank.ca/bio_entities/BE0003625,P07451,Carbonic anhydrase 3,761.0,CA3,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
20,1302692,5281855,DrugBank,Ellagic Acid,DB08846,Ellagic acid,https://www.drugbank.ca/drugs/DB08846,BE0000535,Carbonic anhydrase 4,https://www.drugbank.ca/bio_entities/BE0000535,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20185318,https://www.ncbi.nlm.nih.gov/pubmed/20185318,20185318,,"Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j.bmc.2010.01.076. Epub  2010 Feb 6."
21,1369728,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,CYP2C19,https://www.dgidb.org/genes/CYP2C19,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
22,1369729,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,HSD17B10,https://www.dgidb.org/genes/HSD17B10,,,3028.0,HSD17B10,9606.0,Homo sapiens (human),,,,,,,,
23,1418361,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,TDP1,https://www.dgidb.org/genes/TDP1,,,55775.0,TDP1,9606.0,Homo sapiens (human),,,,,,,,
24,1418362,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,EHMT2,https://www.dgidb.org/genes/EHMT2,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
25,1432872,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,RECQL,https://www.dgidb.org/genes/RECQL,,,5965.0,RECQL,9606.0,Homo sapiens (human),,,,,,,,
26,1456105,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,FEN1,https://www.dgidb.org/genes/FEN1,,,2237.0,FEN1,9606.0,Homo sapiens (human),,,,,,,,
27,1456106,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,VDR,https://www.dgidb.org/genes/VDR,,,7421.0,VDR,9606.0,Homo sapiens (human),,,,,,,,
28,1456107,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,HPGD,https://www.dgidb.org/genes/HPGD,,,3248.0,HPGD,9606.0,Homo sapiens (human),,,,,,,,
29,1456108,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,POLI,https://www.dgidb.org/genes/POLI,,,11201.0,POLI,9606.0,Homo sapiens (human),,,,,,,,
30,1456109,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7048,TGFBR2,https://ctdbase.org/detail.go?type=gene&acc=7048,,,7048.0,TGFBR2,10036.0,Mesocricetus auratus (golden hamster),"Ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TGFBR2 protein]|ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TGFBR2 mrna]",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
31,1456110,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7077,TIMP2,https://ctdbase.org/detail.go?type=gene&acc=7077,,,7077.0,TIMP2,10036.0,Mesocricetus auratus (golden hamster),"Ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TIMP2 protein]",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
32,1456111,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Ellagic acid inhibits the reaction [TNF protein affects the localization of and results in increased activity of RELA protein]|ellagic acid inhibits the reaction [TNF protein results in increased activity of and affects the secretion of CXCL8 protein],,,PMID:27473819,https://www.ncbi.nlm.nih.gov/pubmed/27473819,27473819,,
33,1456112,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of TNF mRNA,,,PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/35179410,35179410,,
34,1456113,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [carbon tetrachloride results in increased expression of TNF protein],,,PMID:35236242,https://www.ncbi.nlm.nih.gov/pubmed/35236242,35236242,,
35,1456114,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [chromium hexavalent ion results in increased expression of TNF protein],,,PMID:36108929,https://www.ncbi.nlm.nih.gov/pubmed/36108929,36108929,,
36,1456115,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [doxorubicin results in increased expression of TNF protein],,,PMID:28815802,https://www.ncbi.nlm.nih.gov/pubmed/28815802,28815802,,
37,1456116,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [glucose results in increased expression of TNF protein]|ellagic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of TNF protein],,,PMID:24877639,https://www.ncbi.nlm.nih.gov/pubmed/24877639,24877639,,
38,1456311,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [isoproterenol results in increased expression of TNF mrna],,,PMID:21762681,https://www.ncbi.nlm.nih.gov/pubmed/21762681,21762681,,
39,1456312,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [phosalone results in increased expression of TNF protein],,,PMID:27965107,https://www.ncbi.nlm.nih.gov/pubmed/27965107,27965107,,
40,1456313,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenate results in increased expression of TNF mrna]|ellagic acid inhibits the reaction [sodium arsenate results in increased expression of TNF protein],,,PMID:29854611,https://www.ncbi.nlm.nih.gov/pubmed/29854611,29854611,,
41,1456314,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenite results in increased expression of TNF protein],,,PMID:29455002|PMID:29864931,https://www.ncbi.nlm.nih.gov/pubmed/29455002|https://www.ncbi.nlm.nih.gov/pubmed/29864931,29455002|29864931,,
42,1456315,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,8792,TNFRSF11A,https://ctdbase.org/detail.go?type=gene&acc=8792,,,8792.0,TNFRSF11A,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein binds to TNFRSF11A protein]|ellagic acid binds to TNFRSF11A protein,,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
43,1456316,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mrna]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mrna]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of RELA protein]|ellagic acid inhibits the reaction [TNFSF11 protein binds to TNFRSF11A protein]|ellagic acid binds to TNFSF11 protein|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC protein]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mrna]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC mrna]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS mrna]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein],,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
44,1456317,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7139,TNNT2,https://ctdbase.org/detail.go?type=gene&acc=7139,,,7139.0,TNNT2,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [isoproterenol results in increased expression of TNNT2 protein],,,PMID:21762681,https://www.ncbi.nlm.nih.gov/pubmed/21762681,21762681,,
45,1456318,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Ellagic acid promotes the reaction [quercetin results in increased phosphorylation of TP53 protein]|pifithrin inhibits the reaction [ellagic acid promotes the reaction [quercetin results in increased phosphorylation of TP53 protein]],,,PMID:15735102,https://www.ncbi.nlm.nih.gov/pubmed/15735102,15735102,,
46,1456447,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of TP53 mRNA,,,PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/35179410,35179410,,
47,1456448,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of TP53 protein,,,PMID:23554011,https://www.ncbi.nlm.nih.gov/pubmed/23554011,23554011,,
48,1456449,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [phosalone results in increased expression of TP53 mrna]|ellagic acid inhibits the reaction [phosalone results in increased expression of TP53 protein],,,PMID:27965107,https://www.ncbi.nlm.nih.gov/pubmed/27965107,27965107,,
49,1456450,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7360,UGP2,https://ctdbase.org/detail.go?type=gene&acc=7360,,,7360.0,UGP2,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of UGP2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
50,1456451,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7375,USP4,https://ctdbase.org/detail.go?type=gene&acc=7375,,,7375.0,USP4,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of USP4 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
51,1456452,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [carbon tetrachloride results in increased expression of VEGFA protein],,,PMID:35236242,https://www.ncbi.nlm.nih.gov/pubmed/35236242,35236242,,
52,1456453,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7453,WARS1,https://ctdbase.org/detail.go?type=gene&acc=7453,,,7453.0,WARS1,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of WARS1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
53,1456454,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7465,WEE1,https://ctdbase.org/detail.go?type=gene&acc=7465,,,7465.0,WEE1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of WEE1 protein,,,PMID:23554011,https://www.ncbi.nlm.nih.gov/pubmed/23554011,23554011,,
54,1456455,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9606.0,Homo sapiens (human),"Ellagic acid inhibits the reaction [XDH protein alternative form results in increased chemical synthesis of uric acid]|ellagic acid inhibits the reaction [XDH protein alternative form results in increased reduction of bis(2,9-dimethyl-1,10-phenanthroline)copper(ii)]",,,PMID:19231354,https://www.ncbi.nlm.nih.gov/pubmed/19231354,19231354,,
55,1456456,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7704,ZBTB16,https://ctdbase.org/detail.go?type=gene&acc=7704,,,7704.0,ZBTB16,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of ZBTB16 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
56,1456596,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7750,ZMYM2,https://ctdbase.org/detail.go?type=gene&acc=7750,,,7750.0,ZMYM2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of ZMYM2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
57,1456597,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,55,ACP3,https://ctdbase.org/detail.go?type=gene&acc=55,,,55.0,ACP3,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of ACP3 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
58,1456598,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,54,ACP5,https://ctdbase.org/detail.go?type=gene&acc=54,,,54.0,ACP5,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mrna],,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
59,1456599,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of AIFM1 protein,,,PMID:23554011,https://www.ncbi.nlm.nih.gov/pubmed/23554011,23554011,,
60,1456600,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Ellagic acid results in increased phosphorylation of AKT1 protein,,,PMID:26986492,https://www.ncbi.nlm.nih.gov/pubmed/26986492,26986492,,
61,1456601,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [carbon tetrachloride results in increased expression of AKT1 protein],,,PMID:35236242,https://www.ncbi.nlm.nih.gov/pubmed/35236242,35236242,,
62,1456602,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606.0,Homo sapiens (human),ALB protein promotes the reaction [ellagic acid results in increased activity of F12 protein],,,PMID:6343536,https://www.ncbi.nlm.nih.gov/pubmed/6343536,6343536,,
63,1456603,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606.0,Homo sapiens (human),Ellagic acid binds to ALB protein,,,PMID:25247703,https://www.ncbi.nlm.nih.gov/pubmed/25247703,25247703,,
64,1456604,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,121642,ALKBH2,https://ctdbase.org/detail.go?type=gene&acc=121642,,,121642.0,ALKBH2,9606.0,Homo sapiens (human),Ellagic acid results in decreased activity of ALKBH2 protein,,,PMID:31088072,https://www.ncbi.nlm.nih.gov/pubmed/31088072,31088072,,
65,1456605,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1176,AP3S1,https://ctdbase.org/detail.go?type=gene&acc=1176,,,1176.0,AP3S1,10036.0,Mesocricetus auratus (golden hamster),"[ellagic acid co-treated with 9,10-dimethyl-1,2-benzanthracene] results in decreased expression of AP3S1 mRNA",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
66,1456606,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of APAF1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
67,1456750,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of APAF1 mRNA,,,PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/35179410,35179410,,
68,1456751,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,429,ASCL1,https://ctdbase.org/detail.go?type=gene&acc=429,,,429.0,ASCL1,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of ASCL1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
69,1456752,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of ASNS mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
70,1456753,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of ATF3 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
71,1456754,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,9474,ATG5,https://ctdbase.org/detail.go?type=gene&acc=9474,,,9474.0,ATG5,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of ATG5 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
72,1456755,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of BAD protein,,,PMID:23554011,https://www.ncbi.nlm.nih.gov/pubmed/23554011,23554011,,
73,1456756,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of BAX mRNA,,,PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/35179410,35179410,,
74,1456757,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenate results in increased expression of BAX mrna],,,PMID:29854611,https://www.ncbi.nlm.nih.gov/pubmed/29854611,29854611,,
75,1456758,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of BCL2 mRNA,,,PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/35179410,35179410,,
76,1456759,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of BCL2 protein,,,PMID:22386815,https://www.ncbi.nlm.nih.gov/pubmed/22386815,22386815,,
77,1456760,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),"[ellagic acid co-treated with resveratrol] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 mrna]",,,PMID:20103723,https://www.ncbi.nlm.nih.gov/pubmed/20103723,20103723,,
78,1456948,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [carbon tetrachloride results in increased expression of BCL2 protein],,,PMID:35236242,https://www.ncbi.nlm.nih.gov/pubmed/35236242,35236242,,
79,1456949,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenate results in decreased expression of BCL2 mrna],,,PMID:29854611,https://www.ncbi.nlm.nih.gov/pubmed/29854611,29854611,,
80,1456950,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,654,BMP6,https://ctdbase.org/detail.go?type=gene&acc=654,,,654.0,BMP6,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of BMP6 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
81,1456951,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2972,BRF1,https://ctdbase.org/detail.go?type=gene&acc=2972,,,2972.0,BRF1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of BRF1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
82,1456952,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,811,CALR,https://ctdbase.org/detail.go?type=gene&acc=811,,,811.0,CALR,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of CALR mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
83,1456953,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Ellagic acid results in decreased activity of CASP3 protein,,,PMID:22386815,https://www.ncbi.nlm.nih.gov/pubmed/22386815,22386815,,
84,1456954,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of CASP3 mrna|ellagic acid results in decreased expression of CASP3 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
85,1456955,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Ellagic acid results in increased activity of CASP3 protein,,,PMID:23811531,https://www.ncbi.nlm.nih.gov/pubmed/23811531,23811531,,
86,1456956,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of and results in increased activity of CASP3 protein,,,PMID:23554011,https://www.ncbi.nlm.nih.gov/pubmed/23554011,23554011,,
87,1456957,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [carbon tetrachloride results in decreased expression of CASP3 protein],,,PMID:35236242,https://www.ncbi.nlm.nih.gov/pubmed/35236242,35236242,,
88,1456958,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [doxorubicin results in increased expression of CASP3 protein],,,PMID:28815802,https://www.ncbi.nlm.nih.gov/pubmed/28815802,28815802,,
89,1457077,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenate results in increased activity of CASP3 protein],,,PMID:29854611,https://www.ncbi.nlm.nih.gov/pubmed/29854611,29854611,,
90,1457078,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of and results in increased activity of CASP9 protein,,,PMID:23554011,https://www.ncbi.nlm.nih.gov/pubmed/23554011,23554011,,
91,1457079,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [carbon tetrachloride results in decreased activity of CAT protein],,,PMID:35236242,https://www.ncbi.nlm.nih.gov/pubmed/35236242,35236242,,
92,1457080,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein],,,PMID:36108929,https://www.ncbi.nlm.nih.gov/pubmed/36108929,36108929,,
93,1457081,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [[dietary fats co-treated with streptozocin] results in decreased activity of CAT protein],,,PMID:24877639,https://www.ncbi.nlm.nih.gov/pubmed/24877639,24877639,,
94,1457082,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein],,,PMID:29864931,https://www.ncbi.nlm.nih.gov/pubmed/29864931,29864931,,
95,1457083,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Ellagic acid results in increased activity of CAT protein,,,PMID:20074268,https://www.ncbi.nlm.nih.gov/pubmed/20074268,20074268,,
96,1457084,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Ellagic acid results in decreased secretion of CCL2 protein,,,PMID:20816778,https://www.ncbi.nlm.nih.gov/pubmed/20816778,20816778,,
97,1457085,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10036.0,Mesocricetus auratus (golden hamster),"Ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of CCND1 protein]|ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of CCND1 mrna]",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
98,1457086,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of CD14 mRNA,,,PMID:20816778,https://www.ncbi.nlm.nih.gov/pubmed/20816778,20816778,,
99,1457207,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of CDK1 protein,,,PMID:23554011,https://www.ncbi.nlm.nih.gov/pubmed/23554011,23554011,,
100,1457208,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),[ellagic acid co-treated with quercetin] results in increased expression of CDKN1A mrna|ellagic acid promotes the reaction [quercetin results in increased expression of CDKN1A protein]|pifithrin inhibits the reaction [ellagic acid promotes the reaction [quercetin results in increased expression of CDKN1A protein]],,,PMID:15735102,https://www.ncbi.nlm.nih.gov/pubmed/15735102,15735102,,
101,1457209,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of CDKN1A protein,,,PMID:23554011,https://www.ncbi.nlm.nih.gov/pubmed/23554011,23554011,,
102,1457210,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090.0,Mus musculus (house mouse),"[resveratrol co-treated with ellagic acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mrna]",,,PMID:20103723,https://www.ncbi.nlm.nih.gov/pubmed/20103723,20103723,,
103,1457211,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,112942,CFAP36,https://ctdbase.org/detail.go?type=gene&acc=112942,,,112942.0,CFAP36,10036.0,Mesocricetus auratus (golden hamster),"[ellagic acid co-treated with 9,10-dimethyl-1,2-benzanthracene] results in increased expression of CFAP36 mRNA",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
104,1457212,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,9606.0,Homo sapiens (human),Ellagic acid binds to COL2A1 protein|ellagic acid inhibits the reaction [MMP13 protein results in increased degradation of COL2A1 protein],,,PMID:23830812,https://www.ncbi.nlm.nih.gov/pubmed/23830812,23830812,,
105,1457213,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [isoproterenol results in increased activity of CTSD protein],,,PMID:21762681,https://www.ncbi.nlm.nih.gov/pubmed/21762681,21762681,,
106,1457214,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1513,CTSK,https://ctdbase.org/detail.go?type=gene&acc=1513,,,1513.0,CTSK,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mrna]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein],,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
107,1457215,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Ellagic acid inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein],,,PMID:18377686,https://www.ncbi.nlm.nih.gov/pubmed/18377686,18377686,,
108,1457216,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Ellagic acid inhibits the reaction [TNF protein results in increased activity of and affects the secretion of CXCL8 protein],,,PMID:27473819,https://www.ncbi.nlm.nih.gov/pubmed/27473819,27473819,,
109,1457332,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of CXCL8 mRNA,,,PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/35179410,35179410,,
110,1457333,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of CYP1A1 mRNA,,,PMID:20816778,https://www.ncbi.nlm.nih.gov/pubmed/20816778,20816778,,
111,1457334,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),Ellagic acid results in decreased activity of CYP1A1 protein,,,PMID:19329757,https://www.ncbi.nlm.nih.gov/pubmed/19329757,19329757,,
112,1457335,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090.0,Mus musculus (house mouse),"[ellagic acid co-treated with plant extracts] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mrna]|[ellagic acid co-treated with resveratrol] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mrna]",,,PMID:20103723,https://www.ncbi.nlm.nih.gov/pubmed/20103723,20103723,,
113,1457336,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090.0,Mus musculus (house mouse),Ellagic acid results in decreased activity of CYP1B1 protein,,,PMID:19329757,https://www.ncbi.nlm.nih.gov/pubmed/19329757,19329757,,
114,1457337,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1616,DAXX,https://ctdbase.org/detail.go?type=gene&acc=1616,,,1616.0,DAXX,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of DAXX mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
115,1457338,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1676,DFFA,https://ctdbase.org/detail.go?type=gene&acc=1676,,,1676.0,DFFA,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of DFFA mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
116,1457339,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,10049,DNAJB6,https://ctdbase.org/detail.go?type=gene&acc=10049,,,10049.0,DNAJB6,10036.0,Mesocricetus auratus (golden hamster),"[ellagic acid co-treated with 9,10-dimethyl-1,2-benzanthracene] results in decreased expression of DNAJB6 mRNA",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
117,1457340,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1877,E4F1,https://ctdbase.org/detail.go?type=gene&acc=1877,,,1877.0,E4F1,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of E4F1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
118,1457341,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1960,EGR3,https://ctdbase.org/detail.go?type=gene&acc=1960,,,1960.0,EGR3,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of EGR3 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
119,1457538,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1995,ELAVL3,https://ctdbase.org/detail.go?type=gene&acc=1995,,,1995.0,ELAVL3,9606.0,Homo sapiens (human),Ellagic acid results in decreased activity of ELAVL3 protein,,,PMID:19192392,https://www.ncbi.nlm.nih.gov/pubmed/19192392,19192392,,
120,1457539,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2021,ENDOG,https://ctdbase.org/detail.go?type=gene&acc=2021,,,2021.0,ENDOG,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of ENDOG protein,,,PMID:23554011,https://www.ncbi.nlm.nih.gov/pubmed/23554011,23554011,,
121,1457540,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of EP300 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
122,1457541,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2060,EPS15,https://ctdbase.org/detail.go?type=gene&acc=2060,,,2060.0,EPS15,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of EPS15 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
123,1457542,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2145,EZH1,https://ctdbase.org/detail.go?type=gene&acc=2145,,,2145.0,EZH1,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of EZH1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
124,1457543,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2161,F12,https://ctdbase.org/detail.go?type=gene&acc=2161,,,2161.0,F12,9606.0,Homo sapiens (human),ALB protein promotes the reaction [ellagic acid results in increased activity of F12 protein]|ellagic acid results in increased activity of F12 protein,,,PMID:6343536,https://www.ncbi.nlm.nih.gov/pubmed/6343536,6343536,,
125,1457544,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2260,FGFR1,https://ctdbase.org/detail.go?type=gene&acc=2260,,,2260.0,FGFR1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of FGFR1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
126,1457545,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2316,FLNA,https://ctdbase.org/detail.go?type=gene&acc=2316,,,2316.0,FLNA,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of FLNA mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
127,1457546,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of FN1 protein],,,PMID:24877639,https://www.ncbi.nlm.nih.gov/pubmed/24877639,24877639,,
128,1457547,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090.0,Mus musculus (house mouse),"[ellagic acid co-treated with plant extracts] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of FOS mrna]|[ellagic acid co-treated with resveratrol] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of FOS mrna]",,,PMID:20103723,https://www.ncbi.nlm.nih.gov/pubmed/20103723,20103723,,
129,1457720,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS mrna],,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
130,1457721,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,9606.0,Homo sapiens (human),Ellagic acid results in decreased activity of G6PD protein,,,PMID:25130191,https://www.ncbi.nlm.nih.gov/pubmed/25130191,25130191,,
131,1457722,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,51083,GAL,https://ctdbase.org/detail.go?type=gene&acc=51083,,,51083.0,GAL,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [phosalone results in increased activity of GAL protein],,,PMID:27965107,https://www.ncbi.nlm.nih.gov/pubmed/27965107,27965107,,
132,1457723,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2822,GPLD1,https://ctdbase.org/detail.go?type=gene&acc=2822,,,2822.0,GPLD1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of GPLD1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
133,1457724,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [diquat results in increased activity of GPT protein],,,PMID:35268077,https://www.ncbi.nlm.nih.gov/pubmed/35268077,35268077,,
134,1457725,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [[dietary fats co-treated with streptozocin] results in increased expression of GPT protein],,,PMID:24877639,https://www.ncbi.nlm.nih.gov/pubmed/24877639,24877639,,
135,1457726,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenite results in increased expression of GPT protein],,,PMID:29935397,https://www.ncbi.nlm.nih.gov/pubmed/29935397,29935397,,
136,1457727,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [diquat results in decreased expression of GPX1 mrna],,,PMID:35268077,https://www.ncbi.nlm.nih.gov/pubmed/35268077,35268077,,
137,1457728,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenite results in decreased expression of GPX1 mrna],,,PMID:29935397,https://www.ncbi.nlm.nih.gov/pubmed/29935397,29935397,,
138,1457729,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [[dietary fats co-treated with streptozocin] results in decreased activity of GSR protein],,,PMID:24877639,https://www.ncbi.nlm.nih.gov/pubmed/24877639,24877639,,
139,1457887,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2941,GSTA4,https://ctdbase.org/detail.go?type=gene&acc=2941,,,2941.0,GSTA4,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of GSTA4 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
140,1457888,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,36927,GSTS1,https://ctdbase.org/detail.go?type=gene&acc=36927,,,36927.0,GstS1,80765.0,Aphis gossypii (cotton aphid),Ellagic acid binds to GSTS1 protein,,,PMID:25512683,https://www.ncbi.nlm.nih.gov/pubmed/25512683,25512683,,
141,1457889,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,692543,GSTS2,https://ctdbase.org/detail.go?type=gene&acc=692543,,,692543.0,,80765.0,Aphis gossypii (cotton aphid),Ellagic acid binds to GSTS2 protein,,,PMID:25512683,https://www.ncbi.nlm.nih.gov/pubmed/25512683,25512683,,
142,1457890,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,10116.0,Rattus norvegicus (Norway rat),Ellagic acid affects the expression of GSTT1 protein,,,PMID:9855024,https://www.ncbi.nlm.nih.gov/pubmed/9855024,9855024,,
143,1457891,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2961,GTF2E2,https://ctdbase.org/detail.go?type=gene&acc=2961,,,2961.0,GTF2E2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of GTF2E2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
144,1457892,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2968,GTF2H4,https://ctdbase.org/detail.go?type=gene&acc=2968,,,2968.0,GTF2H4,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of GTF2H4 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
145,1457893,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,2990,GUSB,https://ctdbase.org/detail.go?type=gene&acc=2990,,,2990.0,GUSB,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [isoproterenol results in increased activity of GUSB protein],,,PMID:21762681,https://www.ncbi.nlm.nih.gov/pubmed/21762681,21762681,,
146,1457894,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of HIF1A mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
147,1457895,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3141,HLCS,https://ctdbase.org/detail.go?type=gene&acc=3141,,,3141.0,HLCS,9606.0,Homo sapiens (human),Ellagic acid results in decreased activity of HLCS protein,,,PMID:26303405,https://www.ncbi.nlm.nih.gov/pubmed/26303405,26303405,,
148,1457896,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),[paraquat co-treated with ellagic acid] results in increased expression of HMOX1 protein|ellagic acid results in increased expression of HMOX1 mrna|[paraquat co-treated with ellagic acid] results in increased expression of HMOX1 mRNA,,,PMID:23546295,https://www.ncbi.nlm.nih.gov/pubmed/23546295,23546295,,
149,1457897,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of HMOX1 protein,,,PMID:22386815|PMID:23546295,https://www.ncbi.nlm.nih.gov/pubmed/22386815|https://www.ncbi.nlm.nih.gov/pubmed/23546295,22386815|23546295,,
150,1458029,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [diquat results in decreased expression of HMOX1 mrna],,,PMID:35268077,https://www.ncbi.nlm.nih.gov/pubmed/35268077,35268077,,
151,1458030,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3190,HNRNPK,https://ctdbase.org/detail.go?type=gene&acc=3190,,,3190.0,HNRNPK,10036.0,Mesocricetus auratus (golden hamster),"[ellagic acid co-treated with 9,10-dimethyl-1,2-benzanthracene] results in decreased expression of HNRNPK mRNA",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
152,1458031,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3265,HRAS,https://ctdbase.org/detail.go?type=gene&acc=3265,,,3265.0,HRAS,10090.0,Mus musculus (house mouse),"[ellagic acid co-treated with plant extracts] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]|[ellagic acid co-treated with resveratrol] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]",,,PMID:20103723,https://www.ncbi.nlm.nih.gov/pubmed/20103723,20103723,,
153,1458032,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,9592,IER2,https://ctdbase.org/detail.go?type=gene&acc=9592,,,9592.0,IER2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of IER2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
154,1458033,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenate results in increased expression of IFNG mrna]|ellagic acid inhibits the reaction [sodium arsenate results in increased expression of IFNG protein],,,PMID:29854611,https://www.ncbi.nlm.nih.gov/pubmed/29854611,29854611,,
155,1458034,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3485,IGFBP2,https://ctdbase.org/detail.go?type=gene&acc=3485,,,3485.0,IGFBP2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of IGFBP2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
156,1458035,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3487,IGFBP4,https://ctdbase.org/detail.go?type=gene&acc=3487,,,3487.0,IGFBP4,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of IGFBP4 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
157,1458036,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Ellagic acid inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein],,,PMID:18377686,https://www.ncbi.nlm.nih.gov/pubmed/18377686,18377686,,
158,1458037,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of IL1B mRNA,,,PMID:20816778,https://www.ncbi.nlm.nih.gov/pubmed/20816778,20816778,,
159,1458038,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [glucose results in increased expression of IL1B protein]|ellagic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of IL1B protein],,,PMID:24877639,https://www.ncbi.nlm.nih.gov/pubmed/24877639,24877639,,
160,1458196,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [isoproterenol results in increased expression of IL1B mrna],,,PMID:21762681,https://www.ncbi.nlm.nih.gov/pubmed/21762681,21762681,,
161,1458197,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [phosalone results in increased expression of IL1B protein],,,PMID:27965107,https://www.ncbi.nlm.nih.gov/pubmed/27965107,27965107,,
162,1458198,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenate results in increased expression of IL1B mrna],,,PMID:29854611,https://www.ncbi.nlm.nih.gov/pubmed/29854611,29854611,,
163,1458199,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenite results in increased expression of IL1B protein],,,PMID:29455002|PMID:29864931,https://www.ncbi.nlm.nih.gov/pubmed/29455002|https://www.ncbi.nlm.nih.gov/pubmed/29864931,29455002|29864931,,
164,1458200,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of IL1R1 mRNA,,,PMID:20816778,https://www.ncbi.nlm.nih.gov/pubmed/20816778,20816778,,
165,1458201,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [glucose results in increased expression of IL6 protein]|ellagic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of IL6 protein],,,PMID:24877639,https://www.ncbi.nlm.nih.gov/pubmed/24877639,24877639,,
166,1458202,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [isoproterenol results in increased expression of IL6 mrna],,,PMID:21762681,https://www.ncbi.nlm.nih.gov/pubmed/21762681,21762681,,
167,1458203,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [phosalone results in increased expression of IL6 protein],,,PMID:27965107,https://www.ncbi.nlm.nih.gov/pubmed/27965107,27965107,,
168,1458204,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3635,INPP5D,https://ctdbase.org/detail.go?type=gene&acc=3635,,,3635.0,INPP5D,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of INPP5D mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
169,1458205,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,10788,IQGAP2,https://ctdbase.org/detail.go?type=gene&acc=10788,,,10788.0,IQGAP2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of IQGAP2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
170,1458344,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,10379,IRF9,https://ctdbase.org/detail.go?type=gene&acc=10379,,,10379.0,IRF9,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of IRF9 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
171,1458345,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of JUN protein modified form|ellagic acid results in decreased expression of JUN mRNA,,,PMID:23811531,https://www.ncbi.nlm.nih.gov/pubmed/23811531,23811531,,
172,1458346,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,354,KLK3,https://ctdbase.org/detail.go?type=gene&acc=354,,,354.0,KLK3,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of KLK3 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
173,1458347,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,9516,LITAF,https://ctdbase.org/detail.go?type=gene&acc=9516,,,9516.0,LITAF,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of LITAF mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
174,1458348,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4130,MAP1A,https://ctdbase.org/detail.go?type=gene&acc=4130,,,4130.0,MAP1A,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of MAP1A mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
175,1458349,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4214,MAP3K1,https://ctdbase.org/detail.go?type=gene&acc=4214,,,4214.0,MAP3K1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of MAP3K1 mrna|ellagic acid results in decreased expression of MAP3K1 protein,,,PMID:23811531,https://www.ncbi.nlm.nih.gov/pubmed/23811531,23811531,,
176,1458350,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein],,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
177,1458351,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5600,MAPK11,https://ctdbase.org/detail.go?type=gene&acc=5600,,,5600.0,MAPK11,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of MAPK11 mRNA,,,PMID:23811531,https://www.ncbi.nlm.nih.gov/pubmed/23811531,23811531,,
178,1458352,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [phosalone results in increased expression of MAPK14 protein],,,PMID:27965107,https://www.ncbi.nlm.nih.gov/pubmed/27965107,27965107,,
179,1458353,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein],,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
180,1458462,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),[ellagic acid co-treated with quercetin] results in increased phosphorylation of MAPK8 protein,,,PMID:15735102,https://www.ncbi.nlm.nih.gov/pubmed/15735102,15735102,,
181,1458463,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606.0,Homo sapiens (human),[ellagic acid co-treated with quercetin] results in increased phosphorylation of MAPK9 protein,,,PMID:15735102,https://www.ncbi.nlm.nih.gov/pubmed/15735102,15735102,,
182,1458464,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4257,MGST1,https://ctdbase.org/detail.go?type=gene&acc=4257,,,4257.0,MGST1,10116.0,Rattus norvegicus (Norway rat),Ellagic acid results in decreased activity of MGST1 protein,,,PMID:16125204,https://www.ncbi.nlm.nih.gov/pubmed/16125204,16125204,,
183,1458465,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,23531,MMD,https://ctdbase.org/detail.go?type=gene&acc=23531,,,23531.0,MMD,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of MMD mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
184,1458466,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4312,MMP1,https://ctdbase.org/detail.go?type=gene&acc=4312,,,4312.0,MMP1,9606.0,Homo sapiens (human),Ellagic acid inhibits the reaction [tobacco smoke pollution results in increased expression of MMP1],,,PMID:22739086,https://www.ncbi.nlm.nih.gov/pubmed/22739086,22739086,,
185,1458467,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9606.0,Homo sapiens (human),Ellagic acid inhibits the reaction [MMP13 protein results in increased degradation of COL2A1 protein],,,PMID:23830812,https://www.ncbi.nlm.nih.gov/pubmed/23830812,23830812,,
186,1458468,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),Zinc chloride inhibits the reaction [ellagic acid results in decreased activity of and results in decreased secretion of MMP2 protein]|ellagic acid results in decreased activity of and results in decreased secretion of MMP2 protein,,,PMID:21573219,https://www.ncbi.nlm.nih.gov/pubmed/21573219,21573219,,
187,1458469,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),Ellagic acid results in decreased activity of MMP2 protein|ellagic acid results in decreased expression of MMP2 mRNA,,,PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/35179410,35179410,,
188,1458470,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10036.0,Mesocricetus auratus (golden hamster),"Ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of MMP2 protein]|ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of MMP2 mrna]",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
189,1458471,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Ellagic acid results in decreased activity of MMP9 protein|ellagic acid results in decreased expression of MMP9 mRNA,,,PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/35179410,35179410,,
190,1458645,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10036.0,Mesocricetus auratus (golden hamster),"Ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of MMP9 mrna]|ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
191,1458646,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4772,NFATC1,https://ctdbase.org/detail.go?type=gene&acc=4772,,,4772.0,NFATC1,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mrna]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein],,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
192,1458647,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),NFE2L2 protein affects the susceptibility to ellagic acid|ellagic acid affects the localization of NFE2L2 protein,,,PMID:22386815,https://www.ncbi.nlm.nih.gov/pubmed/22386815,22386815,,
193,1458648,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of NFE2L2 protein|ellagic acid results in increased expression of and affects the localization of NFE2L2 protein|[paraquat co-treated with ellagic acid] results in increased expression of NFE2L2 mrna|[paraquat co-treated with ellagic acid] results in increased expression of and affects the localization of NFE2L2 protein,,,PMID:23546295,https://www.ncbi.nlm.nih.gov/pubmed/23546295,23546295,,
194,1458649,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of NFE2L2 mRNA,,,PMID:22386815|PMID:23546295,https://www.ncbi.nlm.nih.gov/pubmed/22386815|https://www.ncbi.nlm.nih.gov/pubmed/23546295,22386815|23546295,,
195,1458650,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [diquat results in decreased expression of NFE2L2 mrna]|[ellagic acid co-treated with diquat] results in increased expression of NFE2L2 mRNA,,,PMID:35268077,https://www.ncbi.nlm.nih.gov/pubmed/35268077,35268077,,
196,1458651,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [sodium arsenate results in decreased expression of NFE2L2 mrna]|ellagic acid results in increased expression of NFE2L2 mRNA,,,PMID:30503583,https://www.ncbi.nlm.nih.gov/pubmed/30503583,30503583,,
197,1458652,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [carbon tetrachloride results in decreased expression of NFE2L2 protein],,,PMID:35236242,https://www.ncbi.nlm.nih.gov/pubmed/35236242,35236242,,
198,1458653,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10036.0,Mesocricetus auratus (golden hamster),"Ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of NFKB1 protein]|ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of NFKB1 mrna]",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
199,1458799,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4791,NFKB2,https://ctdbase.org/detail.go?type=gene&acc=4791,,,4791.0,NFKB2,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of NFKB2 mRNA,,,PMID:12002526|PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/12002526|https://www.ncbi.nlm.nih.gov/pubmed/35179410,12002526|35179410,,
200,1458800,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4826,NNAT,https://ctdbase.org/detail.go?type=gene&acc=4826,,,4826.0,NNAT,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of NNAT mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
201,1458801,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,10528,NOP56,https://ctdbase.org/detail.go?type=gene&acc=10528,,,10528.0,NOP56,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of NOP56 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
202,1458802,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of NOS2 mRNA,,,PMID:35179410,https://www.ncbi.nlm.nih.gov/pubmed/35179410,35179410,,
203,1458803,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [doxorubicin results in increased expression of NOS2 protein],,,PMID:28815802,https://www.ncbi.nlm.nih.gov/pubmed/28815802,28815802,,
204,1458804,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4862,NPAS2,https://ctdbase.org/detail.go?type=gene&acc=4862,,,4862.0,NPAS2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of NPAS2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
205,1458805,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of NQO1 protein|[paraquat co-treated with ellagic acid] results in increased expression of NQO1 mrna|ellagic acid results in increased expression of NQO1 mrna|[paraquat co-treated with ellagic acid] results in increased expression of NQO1 protein,,,PMID:23546295,https://www.ncbi.nlm.nih.gov/pubmed/23546295,23546295,,
206,1458806,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [diquat results in decreased expression of NQO1 mrna],,,PMID:35268077,https://www.ncbi.nlm.nih.gov/pubmed/35268077,35268077,,
207,1458807,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),Ellagic acid results in increased activity of NR1I3 protein,,,PMID:21821919,https://www.ncbi.nlm.nih.gov/pubmed/21821919,21821919,,
208,1458808,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,8505,PARG,https://ctdbase.org/detail.go?type=gene&acc=8505,,,8505.0,PARG,9606.0,Homo sapiens (human),Ellagic acid results in decreased activity of PARG protein,,,PMID:19840838,https://www.ncbi.nlm.nih.gov/pubmed/19840838,19840838,,
209,1458958,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [rotenone results in increased cleavage of PARP1 protein],,,PMID:25247703,https://www.ncbi.nlm.nih.gov/pubmed/25247703,25247703,,
210,1458959,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10090.0,Mus musculus (house mouse),"[resveratrol co-treated with ellagic acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of PCNA mrna]",,,PMID:20103723,https://www.ncbi.nlm.nih.gov/pubmed/20103723,20103723,,
211,1458960,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,64714,PDIA2,https://ctdbase.org/detail.go?type=gene&acc=64714,,,64714.0,PDIA2,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [rotenone results in increased nitrosation of and results in decreased activity of PDIA2 protein],,,PMID:25247703,https://www.ncbi.nlm.nih.gov/pubmed/25247703,25247703,,
212,1458961,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5226,PGD,https://ctdbase.org/detail.go?type=gene&acc=5226,,,5226.0,PGD,9606.0,Homo sapiens (human),Ellagic acid results in decreased activity of PGD protein,,,PMID:25130191,https://www.ncbi.nlm.nih.gov/pubmed/25130191,25130191,,
213,1458962,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5320,PLA2G2A,https://ctdbase.org/detail.go?type=gene&acc=5320,,,5320.0,PLA2G2A,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of PLA2G2A mRNA,,,PMID:20816778,https://www.ncbi.nlm.nih.gov/pubmed/20816778,20816778,,
214,1458963,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5355,PLP2,https://ctdbase.org/detail.go?type=gene&acc=5355,,,5355.0,PLP2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of PLP2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
215,1458964,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5371,PML,https://ctdbase.org/detail.go?type=gene&acc=5371,,,5371.0,PML,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of PML mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
216,1458965,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of PPARD mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
217,1458966,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of PPARG protein,,,PMID:23811531,https://www.ncbi.nlm.nih.gov/pubmed/23811531,23811531,,
218,1458967,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10090.0,Mus musculus (house mouse),Ellagic acid results in decreased expression of PPARGC1A mrna|ellagic acid inhibits the reaction [sodium arsenate results in increased expression of PPARGC1A mrna],,,PMID:30503583,https://www.ncbi.nlm.nih.gov/pubmed/30503583,30503583,,
219,1459078,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5592,PRKG1,https://ctdbase.org/detail.go?type=gene&acc=5592,,,5592.0,PRKG1,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of PRKG1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
220,1459079,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5764,PTN,https://ctdbase.org/detail.go?type=gene&acc=5764,,,5764.0,PTN,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of PTN mrna|ellagic acid results in increased expression of PTN mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
221,1459080,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5799,PTPRN2,https://ctdbase.org/detail.go?type=gene&acc=5799,,,5799.0,PTPRN2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of PTPRN2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
222,1459081,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5901,RAN,https://ctdbase.org/detail.go?type=gene&acc=5901,,,5901.0,RAN,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of RAN mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
223,1459082,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [phosalone results in increased expression of RB1 mrna]|ellagic acid inhibits the reaction [phosalone results in increased expression of RB1 protein],,,PMID:27965107,https://www.ncbi.nlm.nih.gov/pubmed/27965107,27965107,,
224,1459083,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,8434,RECK,https://ctdbase.org/detail.go?type=gene&acc=8434,,,8434.0,RECK,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of RECK protein|ellagic acid results in increased expression of RECK mrna|zinc chloride inhibits the reaction [ellagic acid results in increased expression of RECK mrna]|zinc chloride inhibits the reaction [ellagic acid results in increased expression of RECK protein],,,PMID:21573219,https://www.ncbi.nlm.nih.gov/pubmed/21573219,21573219,,
225,1459084,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Ellagic acid inhibits the reaction [TNF protein affects the localization of and results in increased activity of RELA protein],,,PMID:27473819,https://www.ncbi.nlm.nih.gov/pubmed/27473819,27473819,,
226,1459085,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of RELA mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
227,1459086,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10036.0,Mesocricetus auratus (golden hamster),"Ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of RELA mrna]|ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of RELA protein]",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
228,1459087,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of RELA protein],,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
229,1459238,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [carbon tetrachloride results in increased expression of RELA protein],,,PMID:35236242,https://www.ncbi.nlm.nih.gov/pubmed/35236242,35236242,,
230,1459239,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [glucose results in increased expression of RELA protein]|ellagic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of RELA protein],,,PMID:24877639,https://www.ncbi.nlm.nih.gov/pubmed/24877639,24877639,,
231,1459240,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [phosalone results in increased expression of RELA protein],,,PMID:27965107,https://www.ncbi.nlm.nih.gov/pubmed/27965107,27965107,,
232,1459241,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,8490,RGS5,https://ctdbase.org/detail.go?type=gene&acc=8490,,,8490.0,RGS5,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of RGS5 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
233,1459242,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319.0,SCD,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of SCD mRNA,,,PMID:20816778,https://www.ncbi.nlm.nih.gov/pubmed/20816778,20816778,,
234,1459243,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4735,SEPTIN2,https://ctdbase.org/detail.go?type=gene&acc=4735,,,4735.0,SEPTIN2,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of SEPTIN2 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
235,1459244,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,4092,SMAD7,https://ctdbase.org/detail.go?type=gene&acc=4092,,,4092.0,SMAD7,10036.0,Mesocricetus auratus (golden hamster),"Ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of SMAD7 mrna]|ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of SMAD7 protein]",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
236,1459245,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mrna],,,PMID:29935397,https://www.ncbi.nlm.nih.gov/pubmed/29935397,29935397,,
237,1459246,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of SOD3 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
238,1459247,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6652,SORD,https://ctdbase.org/detail.go?type=gene&acc=6652,,,6652.0,SORD,9940.0,Ovis aries (sheep),Ellagic acid results in decreased activity of SORD protein,,,PMID:28153595,https://www.ncbi.nlm.nih.gov/pubmed/28153595,28153595,,
239,1459395,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC protein]|ellagic acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC mrna],,,PMID:32971123,https://www.ncbi.nlm.nih.gov/pubmed/32971123,32971123,,
240,1459396,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10090.0,Mus musculus (house mouse),Ellagic acid inhibits the reaction [sodium arsenate results in decreased expression of STAR mrna]|ellagic acid results in increased expression of STAR mRNA,,,PMID:30503583,https://www.ncbi.nlm.nih.gov/pubmed/30503583,30503583,,
241,1459397,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of STAT3 mRNA,,,PMID:20816778,https://www.ncbi.nlm.nih.gov/pubmed/20816778,20816778,,
242,1459398,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of STAT3 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
243,1459399,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,9013,TAF1C,https://ctdbase.org/detail.go?type=gene&acc=9013,,,9013.0,TAF1C,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of TAF1C mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
244,1459400,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,6938,TCF12,https://ctdbase.org/detail.go?type=gene&acc=6938,,,6938.0,TCF12,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of TCF12 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
245,1459401,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015.0,TERT,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of TERT mRNA alternative form|ellagic acid inhibits the reaction [estradiol results in increased expression of TERT mRNA alternative form],,,PMID:19501078,https://www.ncbi.nlm.nih.gov/pubmed/19501078,19501078,,
246,1459402,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015.0,TERT,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [phosalone results in decreased activity of TERT protein],,,PMID:27965107,https://www.ncbi.nlm.nih.gov/pubmed/27965107,27965107,,
247,1459403,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7019,TFAM,https://ctdbase.org/detail.go?type=gene&acc=7019,,,7019.0,TFAM,9606.0,Homo sapiens (human),Ellagic acid results in decreased expression of TFAM mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
248,1459404,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606.0,Homo sapiens (human),Ellagic acid results in increased expression of TGFB1 mRNA,,,PMID:12002526,https://www.ncbi.nlm.nih.gov/pubmed/12002526,12002526,,
249,1459562,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10036.0,Mesocricetus auratus (golden hamster),"[ellagic acid co-treated with 9,10-dimethyl-1,2-benzanthracene] results in decreased expression of TGFB1 mRNA",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
250,1459563,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116.0,Rattus norvegicus (Norway rat),Ellagic acid inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of TGFB1 protein],,,PMID:24877639,https://www.ncbi.nlm.nih.gov/pubmed/24877639,24877639,,
251,1459564,5281855,Comparative Toxicogenomics Database (CTD),Ellagic Acid,D004610,Ellagic Acid,https://ctdbase.org/detail.go?type=chem&acc=D004610,7046,TGFBR1,https://ctdbase.org/detail.go?type=gene&acc=7046,,,7046.0,TGFBR1,10036.0,Mesocricetus auratus (golden hamster),"Ellagic acid inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TGFBR1 protein]",,,PMID:22485181,https://www.ncbi.nlm.nih.gov/pubmed/22485181,22485181,,
252,1460832,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,RUNX1,https://www.dgidb.org/genes/RUNX1,,,861.0,RUNX1,9606.0,Homo sapiens (human),,,,,,,,
253,1460833,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),207000,PMID:20486938,https://www.ncbi.nlm.nih.gov/pubmed/20486938,20486938,,
254,1460834,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),146000,PMID:20486938,https://www.ncbi.nlm.nih.gov/pubmed/20486938,20486938,,
255,1476524,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,BAZ2B,https://www.dgidb.org/genes/BAZ2B,,,29994.0,BAZ2B,9606.0,Homo sapiens (human),,,,,,,,
256,1476525,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,CBFB,https://www.dgidb.org/genes/CBFB,,,865.0,CBFB,9606.0,Homo sapiens (human),,,,,,,,
257,1484083,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,448,cAMP-Dependent Protein Kinase (PKA),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=448,P00517,cAMP-dependent protein kinase catalytic subunit alpha,282322.0,PRKACA,9913.0,Bos taurus (cattle),,IC50 (nM),600,PMID:7518523,https://www.ncbi.nlm.nih.gov/pubmed/7518523,7518523,,
258,1484084,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,13,Proto-oncogene tyrosine-protein kinase Src,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=13,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,IC50 (nM),300,PMID:7518523,https://www.ncbi.nlm.nih.gov/pubmed/7518523,7518523,,
259,1484085,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,HSPA8,https://www.dgidb.org/genes/HSPA8,,,3312.0,HSPA8,9606.0,Homo sapiens (human),,,,,,,,
260,1484086,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,GLS,https://www.dgidb.org/genes/GLS,,,2744.0,GLS,9606.0,Homo sapiens (human),,,,,,,,
261,1493123,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,APEX1,https://www.dgidb.org/genes/APEX1,,,328.0,APEX1,9606.0,Homo sapiens (human),,,,,,,,
262,1493124,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,MCL1,https://www.dgidb.org/genes/MCL1,,,4170.0,MCL1,9606.0,Homo sapiens (human),,,,,,,,
263,1493125,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,KDM4E,https://www.dgidb.org/genes/KDM4E,,,390245.0,KDM4E,9606.0,Homo sapiens (human),,,,,,,,
264,1549840,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,POLH,https://www.dgidb.org/genes/POLH,,,5429.0,POLH,9606.0,Homo sapiens (human),,,,,,,,
265,1549932,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T16987,Carbonic anhydrase XII (CA-XII),https://idrblab.net/ttd/data/target/details/T16987,O43570,Carbonic anhydrase 12,771.0,CA12,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
266,1549933,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T49639,Heat shock protein 70 (HSP70),https://idrblab.net/ttd/data/target/details/T49639,P0DMV8,Heat shock 70 kDa protein 1A ,3304.0,HSPA1B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
267,1549934,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T49639,Heat shock protein 70 (HSP70),https://idrblab.net/ttd/data/target/details/T49639,P0DMV9,Heat shock 70 kDa protein 1B ,3304.0,HSPA1B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
268,1549935,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
269,1549936,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T31992,Carbonic anhydrase XIV (CA-XIV),https://idrblab.net/ttd/data/target/details/T31992,Q9ULX7,Carbonic anhydrase 14,23632.0,CA14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
270,1549937,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T70977,Glycogen synthase kinase-3 beta (GSK-3B),https://idrblab.net/ttd/data/target/details/T70977,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
271,1549938,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T35445,Mothers against decapentaplegic homolog 3 (SMAD3),https://idrblab.net/ttd/data/target/details/T35445,P84022,Mothers against decapentaplegic homolog 3,4088.0,SMAD3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
272,1549939,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T06569,Carbonic anhydrase VI (CA-VI),https://idrblab.net/ttd/data/target/details/T06569,P23280,Carbonic anhydrase 6,765.0,CA6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
273,1549940,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T62431,Tyrosine-protein kinase SYK (SYK),https://idrblab.net/ttd/data/target/details/T62431,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
274,1549941,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T64567,Carbonic anhydrase IX (CA-IX),https://idrblab.net/ttd/data/target/details/T64567,Q16790,Carbonic anhydrase 9,768.0,CA9,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
275,1549942,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T13201,Carbonic anhydrase I (CA-I),https://idrblab.net/ttd/data/target/details/T13201,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
276,1549943,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T93344,Squalene monooxygenase (SQLE),https://idrblab.net/ttd/data/target/details/T93344,Q14534,Squalene monooxygenase,6713.0,SQLE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
277,1550042,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T53378,Carbonic anhydrase IV (CA-IV),https://idrblab.net/ttd/data/target/details/T53378,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
278,1550043,5281855,Therapeutic Target Database (TTD),Ellagic Acid,D0A1CM,ELLAGIC ACID,https://idrblab.net/ttd/data/drug/details/D0A1CM,T51565,Casein kinase II alpha (CSNK2A1),https://idrblab.net/ttd/data/target/details/T51565,P68400,Casein kinase II subunit alpha,1457.0,CSNK2A1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
279,1558019,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,MAPT,https://www.dgidb.org/genes/MAPT,,,4137.0,MAPT,9606.0,Homo sapiens (human),,,,,,,,
280,1558020,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,6126,DNA primase (Ba DnaG),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6126,,,,,,,,IC50 (nM),>1.00e+5,PMID:24004110,https://www.ncbi.nlm.nih.gov/pubmed/24004110,24004110,,
281,2002661,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,KDM4A,https://www.dgidb.org/genes/KDM4A,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
282,2002662,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,SMAD3,https://www.dgidb.org/genes/SMAD3,,,4088.0,SMAD3,9606.0,Homo sapiens (human),,,,,,,,
283,2015234,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,MAPK1,https://www.dgidb.org/genes/MAPK1,,,5594.0,MAPK1,9606.0,Homo sapiens (human),,,,,,,,
284,2015235,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,HBB,https://www.dgidb.org/genes/HBB,,,3043.0,HBB,9606.0,Homo sapiens (human),,,,,,,,
285,2015236,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,10005,Glutathione transferase (GST),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10005,P09211,Glutathione S-transferase P,2950.0,GSTP1,9606.0,Homo sapiens (human),,IC50 (nM),5.0e+4,PMID:20521884,https://www.ncbi.nlm.nih.gov/pubmed/20521884,20521884,,
286,2015245,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,7629,Aldehyde oxidase (AO),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7629,H9TB17,Aldehyde oxidase 1,100720210.0,Aox1,10141.0,Cavia porcellus (domestic guinea pig),,Ki (nM),4.53e+3,PMID:26722818,https://www.ncbi.nlm.nih.gov/pubmed/26722818,26722818,,
287,2031257,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,POLK,https://www.dgidb.org/genes/POLK,,,51426.0,POLK,9606.0,Homo sapiens (human),,,,,,,,
288,2031258,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,USP2,https://www.dgidb.org/genes/USP2,,,9099.0,USP2,9606.0,Homo sapiens (human),,,,,,,,
289,2031259,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,POLB,https://www.dgidb.org/genes/POLB,,,5423.0,POLB,9606.0,Homo sapiens (human),,,,,,,,
290,2038314,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,PLK1,https://www.dgidb.org/genes/PLK1,,,5347.0,PLK1,9606.0,Homo sapiens (human),,,,,,,,
291,2038315,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,2622,Protein-tyrosine phosphatase 1B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2622,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),7730,,,,,
292,2038335,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,2622,Protein-tyrosine phosphatase 1B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2622,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,Ki (nM),2800,,,,,
293,2038336,5281855,BindingDB,Ellagic Acid,4078,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4078,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),100000,,,,,
294,2057091,5281855,Drug Gene Interaction database (DGIdb),Ellagic Acid,,ELLAGIC ACID,https://www.dgidb.org/drugs/ELLAGIC ACID,,BLM,https://www.dgidb.org/genes/BLM,,,641.0,BLM,9606.0,Homo sapiens (human),,,,,,,,
